-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer … has progressed on or after docetaxel therapy.
Astellas Pharma Inc. is …
-
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
24 Apr 2024 02:54 GMT
… -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer … has progressed on or after docetaxel therapy.
Important Safety Information
For …
-
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
18 Apr 2024 13:00 GMT
… patients with advanced prostate cancer who are relapsed … hematological malignancies and prostate cancer. ONCT-534 is … preclinical activity in prostate cancer models against both … with docetaxel in patients with metastatic castration-resistant prostate cancer …
-
Study finds how adding chemotherapy to hormone therapy helps control locally advanced prostate cancer
17 Apr 2024 21:51 GMT
… with locally advanced prostate cancer provides longer control … advanced, high-risk prostate cancer,” comments Jiahua Pan … of recurrent, progressive prostate cancer.”
The randomized controlled … to prostate cancer. “Our study suggests that neoadjuvant docetaxel- …
-
Science News | Study Finds How Adding Chemotherapy to Hormone Therapy Helps Control Locally Advanced Prostate Cancer
17 Apr 2024 19:15 GMT
… with locally advanced prostate cancer provides longer control … of recurrent, progressive prostate cancer."
The randomized … in locally advanced prostate cancer, but studies have … prostate cancer. "Our study suggests that neoadjuvant docetaxel- …
-
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels
17 Apr 2024 17:08 GMT
… with locally advanced prostate cancer, combined treatment with … risk, locally advanced prostate cancer
The randomized controlled … prostate cancer. "Our study suggests that neoadjuvant docetaxel- … in Locally Advanced Prostate Cancer Treated by Radical …
-
Adding Chemotherapy to Hormone Therapy Helps Control Locally Advanced Prostate Cancer
16 Apr 2024 19:23 GMT
… with locally advanced prostate cancer, combined treatment with … patients with locally advanced prostate cancer, combined treatment with … to prostate cancer. “Our study suggests that neoadjuvant docetaxel- … in locally advanced prostate cancer treated by radical …
-
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
16 Apr 2024 18:55 GMT
… -resistant prostate cancer not previously treated with docetaxel or … androgen receptor pathway inhibitors for metastatic castration-resistant prostate cancer … more broadly in metastatic prostate cancer.
Prostate Cancer Research Alliance (Movember …
-
Analysis Group Researchers Identify Racial Disparities in Treatment of Metastatic Castration-Sensitive Prostate Cancer
16 Apr 2024 17:36 GMT
… patients with metastatic castration-sensitive prostate cancer (mCSPC) since the first … defined TI as patients receiving docetaxel; novel hormonal therapy (abiraterone, … castration-sensitive prostate cancer," was published in April by Prostate Cancer and …
-
Treating Prostate Cancer at Any Stage
16 Apr 2024 16:37 GMT
… causes unrelated to a prostate tumor.
If you' … Then there are metastatic prostate cancers, which spread outside the … the fourth category, oligometastatic prostate cancer, a disease stage on … are medications such as docetaxel, a chemotherapy, and other …